RNAC
Cartesian Therapeutics, Inc. · Healthcare
CTO Metin Kurtoglu sold $1.4M of Cartesian Therapeutics, Inc.
Sold$1,438,038
$17.46Price
82,368Shares
−62%Stake
What RNAC did after the filing
- The stock from Mon, Nov 18 close, $18.57
- −8.8%
- S&P 500, same days
- −0.3%
Measured over 30 trading days, to the Jan 2 close.
Traded Thu, Nov 14. Filed Mon, Nov 18, 2:32 PM ET, during the session. Returns use the Nov 18 close and the Jan 2 close. Not investment advice.